Imaging of malignant liver masses: Characterization and detection

Ultrasound Quarterly

Volumn 22, Issue 1, 2006, Pages 19-29

  Jang, Hyun Jung ^a,b   Kim, Tae Kyoung ^a   Wilson, Stephanie R ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SIEMENS AG   (Germany)

Author keywords

Liver; Liver neoplasms; Microbubbles; US; US contrast

Indexed keywords

CELL DIFFERENTIATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ECHOGRAPHY; EVALUATION; HUMAN; LIVER PARENCHYMA; LIVER TUMOR; PRIORITY JOURNAL; REVIEW;

CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CONTRAST MEDIA; HEMANGIOENDOTHELIOMA; HUMANS; LIVER NEOPLASMS; LYMPHOMA; MICROBUBBLES; NEOPLASM METASTASIS; ULTRASONOGRAPHY;

EID: 33749440432     PISSN: 08948771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Kim TK, Jang HJ, Wilson SR. Imaging diagnosis of hepatocellular carcinoma with differentiation from other pathology. Clin Liver Dis. 2005;9:253-279.
2. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology. 1991;178:493-497.
3. Giorgio A, Ferraioli G, Tarantino L, et al. Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance. AJR Am J Roentgenol. 2004;183:1319-1326.
4. Nicolau C, Catala V, Vilana R, et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol. 2004;14:1092-1099.
5. Lee KHY, O'Malley ME, Haider MA, et al. Triple-phase MDCT of hepatocellular carcinoma. AJR Am J Roentgenol. 2004;182:643-649.
6. Wilson SR, Burns PN, Muradali D, et al. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology. 2000;215:153-161.
7. Kim TK, Choi BI, Han JK, et al. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology. 2000;216:411-417.
8. Brannigan M, Burns PN, Wilson SR. Blood flow patterns in focal liver lesions at microbubble-enhanced US. Radiographics. 2004;24:921-935.
9. Dietrich CF. Characterisation of focal liver lesions with contrast enhanced ultrasonography. Eur J Radiol. 2004;51S:S9-S17.
10. von Herbay A, Vogt C, Willers R, et al. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med. 2004;23:1557-1568.
11. Dill-Macky M, Burns P, Khalili K, et al. Focal hepatic masses: enhancement patterns with SH U 508 A and pulse-inversion US. Radiology. 2002;222:95-102.
12. Wen YL, Kudo M, Zheng RQ, et al. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. AJR Am J Roentgenol. 2004;182:1019-1026.
13. Nicolau C, Bru C. Focal liver lesions: evaluation with contrast-enhanced ultrasonography. Abdom Imaging. 2004;29:348-359.
14. Lim JH, Kim EY, Lee WJ, et al. Regenerative nodules in liver cirrhosis: findings at CT during arterial portography and CT hepatic arteriography with histopathologic correlation. Radiology. 1999;210:451-458.
15. Lim JH, Cho JM, Kim EY, et al. Dysplastic nodules in liver cirrhosis: evaluation of hemodynamics with CT during arterial portography and CT hepatic arteriography. Radiology. 2000;214:869-874.
16. Wilson SR. The liver. In: Rumack CM, Wilson SR, Charboneau JW, eds. Diagnostic Ultrasound, 3rd ed. St Louis, MO: Elsevier Mosby; 2005:126-135.
17. Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology. 2004;232:420-430.
18. Isozaki T, Numata K, Kiba T, et al. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology. 2003;229:798-805.
19. Cosgrove D, Blomley M. Liver tumors: evaluation with contrast-enhanced ultrasound. Abdom Imaging. 2004;29:446-454.
20. Kim TK, Choi BI, Hong HS, et al. Improved imaging of hepatic metastases with delayed pulse inversion harmonic imaging using a contrast agent SH U 508A: preliminary study. Ultrasound Med Biol. 2000;26:1439-1444.
21. Quaia E, Bertolotto M, Forgacs B, et al. Detection of liver metastases by pulse inversion harmonic imaging during Levovist late phase: comparison with conventional ultrasound and helical CT in 160 patients. Eur Radiol. 2003;13:475-483.
22. Hohmann J, Albrecht T, Hoffmann CW, et al. Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents. Eur J Radiol. 2003;46:147-159.
23. Kim TK, Choi BI, Han JK, et al. Peripheral cholangiocarcinoma of the liver: two-phase spiral CT findings. Radiology. 1997;204:539-543.
24. Khalili K, Metser U, Wilson SR. Hilar biliary obstruction: preliminary results with Levovist-enhanced sonography. AJR Am J Roentgenol. 2003;180:687-693.
25. Tonolini M, Cova L, Osti V, et al. Other malignancies. Contrast-Enhanced Ultrasound of Liver Disease. Milan, Italy: Springer; 2003:91.
26. Miller WJ, Dodd GD 3rd, Federle MP, et al. Epithelioid hemangioendothelioma of the liver: imaging findings with pathologic correlation. AJR Am J Roentgenol. 1992;159:53-57.